Literature DB >> 1628036

Octreotide and urinary glycosaminoglycan in Graves' disease.

T C Chang, W C Yao, C C Chang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1628036      PMCID： PMC1882188          DOI： 10.1136/bmj.304.6839.1444

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

1.  Octreotide and Graves' ophthalmopathy.

Authors:  P Perros; R A James; P Kendall-Taylor
Journal:  BMJ       Date:  1992-02-22

2.  Octreotide and Graves' ophthalmopathy and pretibial myxoedema.

Authors:  T C Chang; S C Kao; K M Huang
Journal:  BMJ       Date:  1992-01-18

3.  Purification of a glycosaminoglycan-stimulatory lymphokine from supernatants of in vitro-activated human mononuclear cells.

Authors:  M Tsao; M Ferrarini; C Evans; A Ambro; T L Whiteside
Journal:  Clin Immunol Immunopathol       Date:  1989-01

4.  Somatomedin C in pathogenesis of malignant exophthalmos of endocrine origin.

Authors:  H A Hansson; B Petruson; A Skottner
Journal:  Lancet       Date:  1986-01-25       Impact factor: 79.321

5.  Urinary glycosaminoglycans in Graves' ophthalmopathy.

Authors:  G Kahaly; M Schuler; A C Sewell; G Bernhard; J Beyer; U Krause
Journal:  Clin Endocrinol (Oxf)       Date:  1990-07       Impact factor: 3.478

6.  Short-term somatostatin infusion affects T lymphocyte responsiveness in humans.

Authors:  P Malec; K Zeman; K Markiewicz; H Tchórzewski; Z Nowak; Z Baj
Journal:  Immunopharmacology       Date:  1989 Jan-Feb
  6 in total
  2 in total

Review 1.  An update on diagnostic methods in the investigation of diseases of the thyroid.

Authors:  M J Reinhardt; E Moser
Journal:  Eur J Nucl Med       Date:  1996-05

2.  Lanreotide treatment in a patient with interferon-associated Graves' ophthalmopathy.

Authors:  Deng-Huang Su; Ying-Chun Chang; Shu-Lang Liao; Tien-Chun Chang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-09-28       Impact factor: 3.117
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.